Condition
Irregular Sleep-Wake Syndrome
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
2 terminated out of 2 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Terminated2
Clinical Trials (2)
Showing 2 of 2 trials
NCT03980340Terminated
Breath Biomarkers for Sleep Loss and Circadian Timing
NCT03956745Terminated
Biomarkers for Circadian Timing in Healthy Adults
Showing all 2 trials